scholarly journals Metabolic Syndrome Prevalence in Students Attending West Virginia University

2018 ◽  
Vol 7 (12) ◽  
pp. 487 ◽  
Author(s):  
Melissa Olfert ◽  
Amanda Dent ◽  
Rachel Wattick
Keyword(s):  
Metabolic Syndrome ◽  
Young Adults ◽  
West Virginia ◽  
Type Ii Diabetes ◽  
Behavioral Interventions ◽  
Type Ii Diabetes Mellitus ◽  
Male Students ◽  
P Value ◽  
West Virginia University ◽  
Screening Process

Metabolic Syndrome (MetS) contributes to the development of cardiovascular disease (CVD) and type II diabetes mellitus (T2DM). Few studies have investigated the MetS risk of young adults (18–24 years old). This study aims to determine the prevalence of MetS in Appalachian and non-Appalachian students attending West Virginia University. The prevalence of MetS in this population was 15%. There was no difference in MetS prevalence between male students and female students (18.8% males and 11.1% females, p-value = 0.30), or between Appalachian students and non-Appalachian students (17.7% Appalachian and 10.0% non-Appalachian, p-value = 0.33). Identification of MetS early in life is needed in order to reduce the onset of chronic disease. Therefore, implementing a screening process to identify at-risk young adults will help tailor more effective behavioral interventions.

EFEKTIVITAS PERAWATAN ULKUS DIABETIKUM TERHADAP PENERIMAAN DIRI PASIEN DIABETES MELITUS TIPE II DI ASRI WOUND CARE CENTRE MEDAN

2019 ◽  
Vol 4 (2) ◽  
pp. 178
Author(s):  
Elis Anggeria ◽  
Patimah Sari Siregar
Keyword(s):  
Diabetes Mellitus ◽  
Type Ii Diabetes ◽  
Wound Care ◽  
Type Ii Diabetes Mellitus ◽  
P Value ◽  
Type Ii ◽  
Diabetic Ulcer ◽  
Diabetic Ulcers ◽  
Self Acceptance ◽  
Ulcer Treatment

<p><em>Diabetes mellitus (DM) is a group of metabolic diseases characterized by high levels of glucose in the blood (hyperglycemia) that occurs due to impaired insulin secretion, decreased insulin action, or a result of both. Self-acceptance is the ability and desire of individuals to live with all the characteristics themselves against diabetes mellitus. This study aims to determine the effectiveness of diabetic ulcer treatment on self-acceptance of Type II Diabetes Mellitus patients at Asri Wound Care Center Medan. This study uses quantitative research methods with a quasi-experimental design through the one-group pretest-posttest design approach. The population in the study as many as 20 people, with sampling techniques using saturated sampling, the research sample amounted to 20 people. This study uses a nonparametric statistical test that is paired t-test. The results of research on self-acceptance of patients with type II diabetes mellitus before treatment of diabetic ulcers showed that the majority of self-acceptance was not good, and the self-acceptance of patients after treatment of diabetic ulcers obtained the majority of good self-acceptance. The effectiveness of diabetic ulcer treatment on self-acceptance of type II diabetes mellitus patients obtained significance value p-value = 0.00 (p-value &lt;0.05) then H0 was rejected. This means that there are differences in self-acceptance of type II Diabetes mellitus patients before and after diabetic ulcer treatment at Asri Wound Care Center Medan. Future researchers are expected to discuss more deeply about the factors that affect the self-acceptance of diabetes mellitus patients who are undergoing treatment for diabetic ulcers.</em></p>

Abstract 392: The Plasma Proteome of Tangier Disease Patients Reveals Perturbations of Diabetic and Inflammatory Pathways

2016 ◽  
Vol 36 (suppl_1) ◽  
Author(s):  
James T McParland ◽  
Evanthia Pashos ◽  
Daniel J Rader ◽  
Marina Cuchel
Keyword(s):  
Inflammatory Response ◽  
Type Ii Diabetes ◽  
Enrichment Analysis ◽  
Nonparametric Test ◽  
Type Ii Diabetes Mellitus ◽  
Gene Set Enrichment Analysis ◽  
P Value ◽  
Type Ii ◽  
Tangier Disease ◽  
Inflammatory Pathways

Aim: The ATP-binding cassette transporter 1 (ABCA1) is a membrane protein well known for its role in cholesterol efflux and HDL formation. Recently, ABCA1 has been implicated as playing a key role in other processes, such as insulin secretion and inflammatory response. We sought to further investigate these potential roles through a quantitative proteomics approach. Specifically, we hypothesized that we could detect differential protein signatures in the plasma of Tangier patients that correspond to pathways involved in diabetes and inflammation. Methods: We used SOMAscan® technology (SomaLogic, Boulder, CO, USA) to analyze plasma collected from 5 Tangier disease patients (homozygotes or compound heterozygotes for functional ABCA1 mutations) and 7 normolipidemic controls. We tested for differences in the levels of approximately 1,000 plasma proteins using a nonparametric test (KS). We then performed Ingenuity Canonical Pathway analysis to examine if proteins linked to diabetes and inflammation pathways were significantly more likely to be differentially abundant in the plasma. We corroborated the results using Gene Set Enrichment Analysis (GSEA). Results: We found an enrichment in differentially abundant proteins involved in type II diabetes mellitus signaling (p-value=0.0002) and inflammatory pathways, such as granulocyte adhesion and diapedesis (p-value=2.2*10 -12 ). These results were also corroborated by GSEA, where gene sets corresponding to GO biological processes such as immune response (p-value=0.008) and inflammatory response (p-value=0.032) ranked at the top of the enrichment results. Conclusions: The results from this pilot study support the concept that ABCA1 is implicated in pathways affecting immune and inflammatory response and type II diabetes.

scholarly journals HUBUNGAN ANTARA DIABETES MELLITUS TIPE II DENGAN DERAJAT OSTEOARTHRITIS LUTUT

2021 ◽  
Vol 5 (1) ◽  
pp. 39
Author(s):  
Maruf Hari Subroto ◽  
Basuki Supartono ◽  
Ryan Herardi
Keyword(s):  
Diabetes Mellitus ◽  
Knee Osteoarthritis ◽  
Diabetic Patient ◽  
Type Ii Diabetes ◽  
Cartilage Damage ◽  
Type Ii Diabetes Mellitus ◽  
P Value ◽  
Type Ii ◽  
Keywords Knee ◽  
Diabetes Mellitus Group

Osteoarthritis is a degenerative disease that cause damage to joint cartilage damage. Osteoarthritis affects 151,4 million people in the world, including 27,4 million in Southeast Asia. Osteoarthritis is a disease that is a burden on public health and the country. The prevalence of osteoarthritis is one in four people aged 50 years and individuals aged 65 years are more at risk of developing calcification of the knee joint. Risk factors such as type II Diabetes Mellitus are observed in one of osteoarthritis research. A hispanic study explained the prevalence of osteoarthritis patient are twice as much in diabetic patient than non-diabetic patient. A score of 6.5% of HbA1c test is required to diagnose diabetes. The goal of this study is to find out the connection of type 2 diabetes mellitus and knee osteoarthritis. This research uses observational analytic with cross sectional research design with a total of 45 patient from Orthopedic clinic of Al – Fauzan General Hospital in 2016 – 2019 and analyzed with chi square test. According to the result, the most group of age is elderly about 34 people (75,6%), the most group of gender is women about 34 people (75,6%), the most group of HbA1c is non-diabetes mellitus group about 30 people (66,7%), the most group of osteoarthritis stage is severe de (4) about 28 people (62,2%), and there is no connection between type II diabetes mellitus with the stage of knee osteoarthritis with p value of 0,828 (p > 0.05). this research shows no significant correlation between type II diabetes mellitus and the stage of knee osteoarthritis. Keywords : Knee Osteoarthritis; HbA1c; Type II Diabetes Mellitus AbstrakOsteoarthritis adalah penyakit degeneratif yang disebabkan kerusakan tulang rawan sendi. Osteoarthritis dialami 151,4 juta orang di dunia dan 27,4 juta orang di Asia Tenggara. Osteoarthritis merupakan penyakit yang menjadi beban kesehatan masyarakat dan negara. Prevalensi terjadinya osteoarthritis yaitu satu dari empat orang berusia 50 tahun dan individu berusia lebih dari 65 tahun beresiko mengalami pengapuran sendi lutut. Penelitian osteoarthritis mengamati faktor risiko terjadinya osteoarthritis seperti diabetes mellitus tipe 2. Studi Hispanik menjelaskan prevalensi penderita osteoarthritis dua kali lebih banyak terjadi pada penderita dengan diabetes dibandingkan penderita tanpa diabetes. Pemeriksaan HbA1c direkomendasikan untuk mendiagnosis diabetes, dengan batas nilai 6,5 %. Tujuan penelitian ini adalah untuk mengetahui hubungan antara diabetes mellitus tipe II dengan derajat osteoarthritis lutut. Penelitian ini menggunakan analitik observasional dengan desain penelitian potong lintang dengan jumlah sampel 45 pasien di Poli Orthopedi Rumah Sakit Umum Al – Fauzan tahun 2016 – 2019 dan dianalisa menggunakan uji kai kuadrat. Berdasarkan hasil penelitian, usia terbanyak adalah lansia yaitu 34 orang (75,6 %), jenis kelamin terbanyak adalah perempuan yaitu 34 orang (75,6 %), HbA1c terbanyak adalah non diabetes mellitus yaitu 30 orang (66,7 %), derajat osteoarthritis lutut terbanyak adalah derajat berat (4) yaitu 28 orang (62,2 %), dan tidak terdapat hubungan yang bermakna antara diabetes mellitus tipe II dengan derajat osteoarthritis lutut dengan nilai p sebesar 0,828 (p > 0,05). Penelitian ini menunjukan tidak terdapat hubungan yang bermakna antara diabetes mellitus tipe II dengan derajat osteoarthritis lutut

scholarly journals Diastolic dysfunction in cases with Type II diabetes mellitus.

2019 ◽  
Vol 26 (12) ◽  
pp. 2040-2043
Author(s):  
Munir Ahmed ◽  
Abdul Hayee ◽  
Shahla Afsheen Memon ◽  
Ismail Salim Memon ◽  
Abdul Qayoom Memon
Keyword(s):  
Diabetes Mellitus ◽  
Diastolic Dysfunction ◽  
Type Ii Diabetes ◽  
Female Gender ◽  
Type Ii Diabetes Mellitus ◽  
P Value ◽  
Type I ◽  
Type Ii ◽  
Cross Sectional ◽  
Significant Difference

Objectives: To determine the frequency of diastolic dysfunction in patients presenting with type II Diabetes Mellitus. Study Design: Cross sectional study. Setting: Sheikh Zayed Hospital, Rahim Yar Khan. Period: From 01-01-2017 to 30-06-2017. Material & Methods: In this study the cases were selected via non probability consecutive sampling of both male and female gender with age more than 40 years having type II DM of at least more than 2 years were included. The cases suffering from type I DM, gestational DM and those with HTN, end stage kidney and liver failure were excluded. Trans thoracic echocardiography was done to label diastolic dysfunction and was labelled as yes when the E/A ratio was <0.8. The data was analysed using chi square test and p value less than 0.05 was taken as significant. Results: In this study, 100 cases of type II DM were included with mean age of 51.31±7.89 years at presentation. There were 61% males and 39% females. Diastolic dysfunction was observed in 53% of the cases. There was no significant difference in terms of gender where it affected 56.41% of females with p= 0.92. Diastolic dysfunction was more in cases that had duration of DM more than 3 years affecting 48 (70.58%) cases with p= 0.001 and it was also significantly high in cases that had BMI more than 30 where it was seen in 40 (70.17%) of cases with p= 0.001. Conclusion: Diastolic dysfunction seen in half of the cases suffering from type II DM and it is significantly high in cases that had duration of DM more than 3 years and BMI more than 30.

scholarly journals Serum chromium, glycosylated hemoglobin level and body mass index among control and uncontrol sudanese patients with type II diabetes mellitus: Correlation study

2021 ◽  
Vol 16 (2) ◽  
pp. 196-203
Author(s):  
Nassr Eldin M. A. shrif ◽  
Ahmed Mohamed Ahmed Dawood ◽  
Abdelmahmoud Mokhtar Bashir ◽  
Hassan Mohammed Khair Ibrahim ◽  
Abd Elgadir A Altoum
Keyword(s):  
Diabetes Mellitus ◽  
Type Ii Diabetes ◽  
Glycosylated Hemoglobin ◽  
Type Ii Diabetes Mellitus ◽  
P Value ◽  
Diabetic Patients ◽  
Type Ii ◽  
Chromium Level ◽  
Serum Chromium ◽  
R Value

Background: Chromium is an essential micronutrient which is required for the normal functioning of insulin and regulation of blood sugar levels. It acts as a vital antioxidant for maintaining insulin homeostasis. In diabetes mellitus, the free radical production is increased and levels of antioxidants like chromium, vanadium, selenium and manganese are reduced. Aim: To study the level of serum chromium level in patients with type 2 diabetes mellitus and its association with glycemic control. Materials and Methods: One hundred and twenty individuals were enrolled in this study, classified into 60 type II diabetes mellitus (type II DM) patients and 60 apparently health as control group. Serum chromium and Glycosylated Hemoglobin (HbA1c) level were measured using atomic absorption spectrometry and Ichroma. Results: The results showed significant decrease in serum chromium level in type II DM patients (0.0151±0.005) when compared with healthy group (0.122±0.691) with p-value (0.002). In addition to that there was significant decrease in mean concentration of serum chromium level in controlled diabetic patients (0.0206± 0.003) when compared with uncontrolled diabetic patients (0.0120±0.002) with P-value (0.04).Also there was significant positive correlation between chromium level and Body Mass Index (BMI) (R-value 0.450, P-value 0.014), and significant negative correlation between chromium level and age (R-value- 0.660, P-value 0.011) , a significant strong negative correlation between chromium level and HbA1c (R-value -0.843, P-value 0.0260). Conclusion: The study concluded that, serum chromium level is significantly decrease in type II DM.

scholarly journals Role of Apo B and Apo A1 Levels in Relation to Conventional Lipid Profile in Patients of Ischaemic Heart Disease with or without Type II Diabetes Mellitus

2021 ◽  
Author(s):  
Hardik N Javia ◽  
Milav H Bhavsar ◽  
Bhavesh R Sadariya ◽  
Amitkumar V Maheshwari ◽  
Hariom Sharma
Keyword(s):  
Diabetes Mellitus ◽  
Lipid Profile ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
P Value ◽  
Type Ii ◽  
Apo B ◽  
Group Iii ◽  
Group I ◽  
Group Ii

Introduction: Ischaemic Heart Disease (IHD) or Coronary Artery Disease (CAD) is the most prevalent chronic disease and the main leading cause of death in the world, with more than half a million newly diagnosed IHD patients each year. Central to this are disorders of lipoprotein metabolism. Apolipoprotein B (Apo B) and Apolipoprotein A1 (Apo A1) are structural and functional components of lipoprotein particles that serve as transporters of cholesterol. Apo B and Apo A1 are among the emerging markers for Cardiovascular Diseases (CVD). Routine conventional lipid profile does not incorporate these markers. Aim: To determine the level of Apo A1 and Apo B in patients of IHD with or without Type II Diabetes Mellitus (T2DM) and analyse the significance of these parameters over the conventional lipid profile. Materials and Methods: The case-control study was conducted at Government Medical College, Bhavnagar, Gujarat, India from July 2013 to December 2013. The study consists of 100 participants including 50 having IHD only (Group I), 50 having IHD with T2DM (Group II) as study groups and 50 healthy individuals (Group III) as control. Various biochemical parameters including Apo B and Apo A1 were analysed and statistically evaluated to come to conclusion. Results: The demographic details of the participants which shows no significant different in age and gender among groups I, II and III. Apo B and A1 were elevated in group I and II and were found highly significant (p-value <0.0001) as compared to the group III. There was positive correlation of serum Apo B levels with total cholesterol (r=0.495, p-value <0.0001), Low-Density Lipoproteins (LDL-C) (r=0.526, p-value <0.0001) and Apo A1 (r=0.685, p-value <0.0001) in group I and LDL-C (r=0.468, p-value=0.001) and Apo A1 (r=0.754, p-value <0.0001) in group II. Similarly, Apo A1 levels were positively correlated with Apo B (r=0.685, p<0.0001) in group I and LDL-C (r=0.305, p-value=0.031) and Apo B (r=0.754, p-value <0.0001) in group II. Conclusion: As the Apo B and Apo A1 cover both atherogenic and antiatherogenic lipid parameters respectively, it can be used as a better predictor of development of IHD with and without T2DM in comparison to conventional parameters of lipid profile.

Sign in / Sign up

Export Citation Format

Share Document